FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120269913> ?p ?o ?g. }

• W3120269913 endingPage "149" @default.
• W3120269913 startingPage "142" @default.
• W3120269913 abstract "A large number of studies indicate that subanesthetic doses of ketamine induce a fast antidepressant effect. Limited studies have investigated the subcutaneous (SC) route, and it remains unclear for whom this treatment is most suitable.The aim of this study was to examine the effect on depressive symptoms of repeated subanesthetic doses of SC esketamine in unipolar and bipolar treatment-resistant depression (TRD) and clinical predictors of response.A retrospective analysis of 70 patients who received six SC esketamine doses weekly as an adjunctive treatment was carried out. Doses started at 0.5 mg/kg and it could be titrated up to 1 mg/kg, according to response. The primary outcome was reduction in depressive symptoms. Statistical analysis to investigate clinical predictors of effectiveness included logistic regression analysis using a dependent variable of a 50% reduction in rating scale scores at the end of treatment. Comparisons between groups were made through analysis of variance and treatment effects.At baseline, our sample presented with severe treatment resistance in 65.7%, as assessed by the Maudsley Staging Method (MSM), and 47.1% had anxiety disorder comorbidity. The response rate was 50%. A better outcome was predicted by mild and moderate MSM scores (OR = 3.162, p = 0.041) and anxiety disorder comorbidity (OR = 3.149, p = 0.028).Our results suggest that higher levels of treatment resistance may be associated with a poor response to SC esketamine. Unlike traditional pharmacotherapies, it might benefit those with poor prognosis such as patients with depression and comorbid anxiety. Therefore, future research could investigate whether esketamine should receive a more prominent place in the treatment algorithm for TRD." @default.
• W3120269913 created "2021-01-18" @default.
• W3120269913 creator A5015915047 @default.
• W3120269913 creator A5017789434 @default.
• W3120269913 creator A5019309575 @default.
• W3120269913 creator A5021122222 @default.
• W3120269913 creator A5024651040 @default.
• W3120269913 creator A5030987781 @default.
• W3120269913 creator A5031348440 @default.
• W3120269913 creator A5031695884 @default.
• W3120269913 creator A5033265632 @default.
• W3120269913 creator A5033669948 @default.
• W3120269913 creator A5037401058 @default.
• W3120269913 creator A5043894191 @default.
• W3120269913 creator A5052155853 @default.
• W3120269913 creator A5053407427 @default.
• W3120269913 creator A5053854246 @default.
• W3120269913 creator A5056572019 @default.
• W3120269913 creator A5074815215 @default.
• W3120269913 creator A5087677503 @default.
• W3120269913 date "2021-01-09" @default.
• W3120269913 modified "2023-10-03" @default.
• W3120269913 title "Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity" @default.
• W3120269913 cites W1746596066 @default.
• W3120269913 cites W1948877773 @default.
• W3120269913 cites W1986936647 @default.
• W3120269913 cites W1995422036 @default.
• W3120269913 cites W2005055479 @default.
• W3120269913 cites W2011063704 @default.
• W3120269913 cites W2023081218 @default.
• W3120269913 cites W2026718830 @default.
• W3120269913 cites W2037227674 @default.
• W3120269913 cites W2038955452 @default.
• W3120269913 cites W2056645337 @default.
• W3120269913 cites W2090676810 @default.
• W3120269913 cites W2091363925 @default.
• W3120269913 cites W2093274439 @default.
• W3120269913 cites W2106636235 @default.
• W3120269913 cites W2108592835 @default.
• W3120269913 cites W2132324173 @default.
• W3120269913 cites W2146659162 @default.
• W3120269913 cites W2149402043 @default.
• W3120269913 cites W2291443053 @default.
• W3120269913 cites W2320782138 @default.
• W3120269913 cites W2328324756 @default.
• W3120269913 cites W2545381381 @default.
• W3120269913 cites W2567253990 @default.
• W3120269913 cites W2608289281 @default.
• W3120269913 cites W2625860417 @default.
• W3120269913 cites W2730146128 @default.
• W3120269913 cites W2738547767 @default.
• W3120269913 cites W2752700145 @default.
• W3120269913 cites W2753744831 @default.
• W3120269913 cites W2779386549 @default.
• W3120269913 cites W2789464286 @default.
• W3120269913 cites W2796940952 @default.
• W3120269913 cites W2796957480 @default.
• W3120269913 cites W2802678418 @default.
• W3120269913 cites W2890154361 @default.
• W3120269913 cites W2893295941 @default.
• W3120269913 cites W2895589451 @default.
• W3120269913 cites W2895737053 @default.
• W3120269913 cites W2904194422 @default.
• W3120269913 cites W2946661342 @default.
• W3120269913 cites W2970337210 @default.
• W3120269913 cites W2970453706 @default.
• W3120269913 cites W2973250424 @default.
• W3120269913 cites W2981272605 @default.
• W3120269913 cites W2986296475 @default.
• W3120269913 cites W3004365315 @default.
• W3120269913 cites W3041772408 @default.
• W3120269913 cites W3045249492 @default.
• W3120269913 cites W4210786464 @default.
• W3120269913 doi "https://doi.org/10.1177/0269881120978398" @default.
• W3120269913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33427015" @default.
• W3120269913 hasPublicationYear "2021" @default.
• W3120269913 type Work @default.
• W3120269913 sameAs 3120269913 @default.
• W3120269913 citedByCount "15" @default.
• W3120269913 countsByYear W31202699132021 @default.
• W3120269913 countsByYear W31202699132022 @default.
• W3120269913 countsByYear W31202699132023 @default.
• W3120269913 crossrefType "journal-article" @default.
• W3120269913 hasAuthorship W3120269913A5015915047 @default.
• W3120269913 hasAuthorship W3120269913A5017789434 @default.
• W3120269913 hasAuthorship W3120269913A5019309575 @default.
• W3120269913 hasAuthorship W3120269913A5021122222 @default.
• W3120269913 hasAuthorship W3120269913A5024651040 @default.
• W3120269913 hasAuthorship W3120269913A5030987781 @default.
• W3120269913 hasAuthorship W3120269913A5031348440 @default.
• W3120269913 hasAuthorship W3120269913A5031695884 @default.
• W3120269913 hasAuthorship W3120269913A5033265632 @default.
• W3120269913 hasAuthorship W3120269913A5033669948 @default.
• W3120269913 hasAuthorship W3120269913A5037401058 @default.
• W3120269913 hasAuthorship W3120269913A5043894191 @default.
• W3120269913 hasAuthorship W3120269913A5052155853 @default.
• W3120269913 hasAuthorship W3120269913A5053407427 @default.
• W3120269913 hasAuthorship W3120269913A5053854246 @default.

• next